Clinical Trial Update: EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL. [Phase 2]

View source ↗

Summary

Phase 2 randomized controlled trial evaluating roflumilast for flexural (inverse/intertriginous) and genital psoriasis; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Eman Raafat Said | Conditions: Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital Psoriasis | Phase 2 | Status: NOT_YET_RECRUITING